Tango Therapeutics, Inc. (TNGX)
20.29
-1.34
(-6.20%)
USD |
NASDAQ |
Apr 06, 16:00
20.25
-0.04
(-0.20%)
After-Hours: 05:06
Tango Therapeutics SG&A Expense (TTM) : 41.51M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Revolution Medicines, Inc. | 195.04M |
| Kodiak Sciences, Inc. | 52.02M |
| Recursion Pharmaceuticals, Inc. | 176.59M |
| AbbVie, Inc. | 14.01B |
| Terns Pharmaceuticals, Inc. | 32.24M |